Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?

Oluwanisola Akanji Onigbinde

doi:10.5455/umj.20210219111336

2023, Vol: 9, Issue: 1

9/1Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Copyright Form
Cover Letter
Title Page

« Previous Article

Letter to the Editor

Ulutas Med J. 2021; 7(2): 141-144

doi: 10.5455/umj.20210219111336

Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?

Oluwanisola Akanji Onigbinde.

Cited By: 1

Abstract
Since late December 2019 to date, the world has continued in the fight against the recent most dreaded coronavirus, severe acute respiratory syndrome 2 (SARS-CoV-2) that is ravaging the world. With the daily geometric increased in infected cases and death toll globally, it was predicted that Africa will suffer the most from the havoc of the coronavirus disease 2019 (COVID-19) pandemic. This prediction could be traced to the dilapidated health care delivery systems, overcrowding, and the high rate of corruption in the continent. However, the claws of this virus seem to have spared the shores of Africa as the death toll in this continent is too low if compared with developed countries with state-of-the-earth facilities. This has led to Africans claim of immunity or resistance to SARS-CoV-2 and that the virus is a 'White man's virus'. Are Africans truly immune to SARS-CoV-2? Should this self-acclaimed immunity or resistance be explored or ignored? Hence this study.

Key words: SARS-CoV-2, Africa, immunity, resistance, COVID-19

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Oluwanisola Akanji Onigbinde
	on Google
	on Google Scholar

This Article Cited By the following articles

COVID-19 vaccination and herd immunity In Africa: An incentive-based approach could be the game-changer to vaccine hesitancy Public Health in Practice 2022; 4(): 100282.	1

How to Cite this Article

Pubmed Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J. 2021; 7(2): 141-144. doi:10.5455/umj.20210219111336

Web Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. https://www.ulutasmedicaljournal.com/?mno=57378 [Access: March 26, 2023]. doi:10.5455/umj.20210219111336

AMA (American Medical Association) Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J. 2021; 7(2): 141-144. doi:10.5455/umj.20210219111336

Vancouver/ICMJE Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J. (2021), [cited March 26, 2023]; 7(2): 141-144. doi:10.5455/umj.20210219111336

Harvard Style

Oluwanisola Akanji Onigbinde (2021) Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J, 7 (2), 141-144. doi:10.5455/umj.20210219111336

Turabian Style

Oluwanisola Akanji Onigbinde. 2021. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. THE ULUTAS MEDICAL JOURNAL, 7 (2), 141-144. doi:10.5455/umj.20210219111336

Chicago Style

Oluwanisola Akanji Onigbinde. "Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?." THE ULUTAS MEDICAL JOURNAL 7 (2021), 141-144. doi:10.5455/umj.20210219111336

MLA (The Modern Language Association) Style

Oluwanisola Akanji Onigbinde. "Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?." THE ULUTAS MEDICAL JOURNAL 7.2 (2021), 141-144. Print. doi:10.5455/umj.20210219111336

APA (American Psychological Association) Style

Oluwanisola Akanji Onigbinde (2021) Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. THE ULUTAS MEDICAL JOURNAL, 7 (2), 141-144. doi:10.5455/umj.20210219111336

Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Privacy Policy Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information



Copyright © 2023 THE ULUTAS MEDICAL JOURNAL All Rights Reserved. Subject to change without notice from or liability to THE ULUTAS MEDICAL JOURNAL. For best results, please use Internet Explorer or Google Chrome	Contact Information Journal Owner HAYRİYE ZEHRA ULUTAŞ Phone: +90 (532) 165 96 39 *E-mail: zehrakenanoglu@hotmail.com Address: Alaattin Mah. 30. Ada sok. D11 Blok No:4 Gungor Uydukent Sitesi Antakya/HATAY Editor-In-Chief* KEMAL TURKER ULUTAS, MD, Assc. Prof. Phone: + 90 (555) 491 35 59 *E-mail: drkemalturker@gmail.com Address: Alaattin Mah. 30. Ada sok. D11 Blok No:4 Gungor Uydukent Sitesi Antakya/HATAY Publisher Information* SCOPEMED Publishing Co. - TURKEY E-mail: scopemed@scopemed.org *Web: https://www.scopemed.com/ We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com* We will respond within 48 to 72 hours.

Contact Information

How to cite this article